Literature DB >> 21674675

Correlation of dyskerin expression with active proliferation independent of telomerase.

Faizan Alawi1, Ping Lin, Barry Ziober, Reena Patel.   

Abstract

BACKGROUND: Dyskerin, which is an important component of the telomerase complex and is needed for normal telomerase activity, is frequently overexpressed in neoplasia. Dyskerin also plays an essential role in ribosome biogenesis. Because protein synthesis increases during tumorigenesis, this led us to hypothesize that dyskerin expression would be upregulated independently of the cell immortalization mechanism.
METHODS: Dyskerin and telomerase reverse transcriptase (TERT) expression were examined in oral squamous cell carcinomas (OSCC) and patient-matched controls, as well as in a panel of telomerase-positive and telomerase-negative cells. Antisense inhibition of TERT was used to test the effects of downregulation of telomerase on dyskerin expression.
RESULTS: Dyskerin was frequently overexpressed in OSCC and in immortalized and transformed keratinocytes relative to primary cells, independently of TERT and telomerase activity. Instead, dyskerin expression strongly correlated with cell proliferation rates.
CONCLUSIONS: The role of dyskerin in tumorigenesis does not correlate with its function within the telomerase complex.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21674675      PMCID: PMC3116033          DOI: 10.1002/hed.21579

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  53 in total

Review 1.  Alternative lengthening of telomeres, telomerase, and cancer.

Authors:  Roger R Reddel
Journal:  Cancer Lett       Date:  2003-05-15       Impact factor: 8.679

Review 2.  Telomerase therapeutics for cancer: challenges and new directions.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Nat Rev Drug Discov       Date:  2006-06-09       Impact factor: 84.694

3.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

Authors:  Michael Hummel; Stefan Bentink; Hilmar Berger; Wolfram Klapper; Swen Wessendorf; Thomas F E Barth; Heinz-Wolfram Bernd; Sergio B Cogliatti; Judith Dierlamm; Alfred C Feller; Martin-Leo Hansmann; Eugenia Haralambieva; Lana Harder; Dirk Hasenclever; Michael Kühn; Dido Lenze; Peter Lichter; Jose Ignacio Martin-Subero; Peter Möller; Hans-Konrad Müller-Hermelink; German Ott; Reza M Parwaresch; Christiane Pott; Andreas Rosenwald; Maciej Rosolowski; Carsten Schwaenen; Benjamin Stürzenhofecker; Monika Szczepanowski; Heiko Trautmann; Hans-Heinrich Wacker; Rainer Spang; Markus Loeffler; Lorenz Trümper; Harald Stein; Reiner Siebert
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

4.  Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.

Authors:  Andrew Yoon; Guang Peng; Yves Brandenburger; Yves Brandenburg; Ornella Zollo; Wei Xu; Eduardo Rego; Davide Ruggero
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

5.  Clinical usefulness of telomerase activation and telomere length in head and neck cancer.

Authors:  Mintoo M Patel; Lalit J Parekh; Franky P Jha; Rachana N Sainger; Jayendra B Patel; Devendra D Patel; Pankaj M Shah; Prabhudas S Patel
Journal:  Head Neck       Date:  2002-12       Impact factor: 3.147

6.  Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.

Authors:  Laura L Smith; Hilary A Coller; James M Roberts
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

Review 7.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

8.  Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.

Authors:  L Montanaro; M Brigotti; J Clohessy; S Barbieri; C Ceccarelli; D Santini; M Taffurelli; M Calienni; J Teruya-Feldstein; D Trerè; P P Pandolfi; M Derenzini
Journal:  J Pathol       Date:  2006-09       Impact factor: 7.996

9.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.

Authors:  Davide Ruggero; Silvia Grisendi; Francesco Piazza; Eduardo Rego; Francesca Mari; Pulivarthi H Rao; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

10.  SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes.

Authors:  Bernice R Packer; Meredith Yeager; Laura Burdett; Robert Welch; Michael Beerman; Liqun Qi; Hugues Sicotte; Brian Staats; Mekhala Acharya; Andrew Crenshaw; Andrew Eckert; Vinita Puri; Daniela S Gerhard; Stephen J Chanock
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  14 in total

1.  Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.

Authors:  Faizan Alawi; Ping Lin
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

2.  Differential requirements for H/ACA ribonucleoprotein components in cell proliferation and response to DNA damage.

Authors:  Ping Lin; Maral E Mobasher; Yasaman Hakakian; Veena Kakarla; Anum F Naseem; Heliya Ziai; Faizan Alawi
Journal:  Histochem Cell Biol       Date:  2015-08-12       Impact factor: 4.304

3.  Acute dyskerin depletion triggers cellular senescence and renders osteosarcoma cells resistant to genotoxic stress-induced apoptosis.

Authors:  Ping Lin; Maral E Mobasher; Faizan Alawi
Journal:  Biochem Biophys Res Commun       Date:  2014-03-29       Impact factor: 3.575

Review 4.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

5.  The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells.

Authors:  Yick W Fong; Jaclyn J Ho; Carla Inouye; Robert Tjian
Journal:  Elife       Date:  2014-11-19       Impact factor: 8.140

Review 6.  Turning Uridines around: Role of rRNA Pseudouridylation in Ribosome Biogenesis and Ribosomal Function.

Authors:  Marianna Penzo; Lorenzo Montanaro
Journal:  Biomolecules       Date:  2018-06-05

7.  Telomere Length Maintenance and Its Transcriptional Regulation in Lynch Syndrome and Sporadic Colorectal Carcinoma.

Authors:  Lilit Nersisyan; Lydia Hopp; Henry Loeffler-Wirth; Jörg Galle; Markus Loeffler; Arsen Arakelyan; Hans Binder
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

8.  Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.

Authors:  Bei Liu; Jinglei Zhang; Chen Huang; Hui Liu
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

9.  Collagen XVI induces expression of MMP9 via modulation of AP-1 transcription factors and facilitates invasion of oral squamous cell carcinoma.

Authors:  Konstanze B Bedal; Susanne Grässel; Peter J Oefner; Joerg Reinders; Torsten E Reichert; Richard Bauer
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Inhibition of human dyskerin as a new approach to target ribosome biogenesis.

Authors:  Laura Rocchi; Arménio J M Barbosa; Carmine Onofrillo; Alberto Del Rio; Lorenzo Montanaro
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.